Christopher Godfrey

511 total citations
17 papers, 331 citations indexed

About

Christopher Godfrey is a scholar working on Molecular Biology, Clinical Psychology and Oncology. According to data from OpenAlex, Christopher Godfrey has authored 17 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Clinical Psychology and 3 papers in Oncology. Recurrent topics in Christopher Godfrey's work include Protein Degradation and Inhibitors (3 papers), Peptidase Inhibition and Analysis (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Christopher Godfrey is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Peptidase Inhibition and Analysis (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Christopher Godfrey collaborates with scholars based in United States, United Kingdom and Australia. Christopher Godfrey's co-authors include Kevin Sweeney, Joel M. Kremer, Robert A. Hamilton, Herbert H. Krauss, J M Kirk, David M. Eisenberg, David B. Morton, Ivan M. Sharman, Richard D. Verschoyle and Roger Ewbank and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Pharmaceutical Research.

In The Last Decade

Christopher Godfrey

15 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Godfrey United States 8 63 52 45 40 32 17 331
Marvin J. Rapaport United States 16 55 0.9× 21 0.4× 34 0.8× 31 0.8× 19 0.6× 41 789
Gabriel P McKeon United States 12 97 1.5× 101 1.9× 20 0.4× 9 0.2× 28 0.9× 17 413
Anthony M. Downs United Kingdom 15 96 1.5× 11 0.2× 98 2.2× 27 0.7× 13 0.4× 41 746
Helen V. Ratajczak United States 15 85 1.3× 35 0.7× 96 2.1× 9 0.2× 72 2.3× 43 691
Mohd Asnizam Asari Malaysia 12 131 2.1× 11 0.2× 28 0.6× 26 0.7× 10 0.3× 50 457
Qiaoling Li China 14 159 2.5× 12 0.2× 17 0.4× 24 0.6× 29 0.9× 36 664
J. A. Barnes United Kingdom 10 116 1.8× 70 1.3× 32 0.7× 7 0.2× 12 0.4× 27 503
Xiaoyu Niu China 13 166 2.6× 13 0.3× 22 0.5× 9 0.2× 44 1.4× 65 539
Rashmi Srivastava India 12 49 0.8× 12 0.2× 56 1.2× 34 0.8× 7 0.2× 33 327
Sunil K Joshi India 5 142 2.3× 12 0.2× 25 0.6× 9 0.2× 14 0.4× 7 487

Countries citing papers authored by Christopher Godfrey

Since Specialization
Citations

This map shows the geographic impact of Christopher Godfrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Godfrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Godfrey more than expected).

Fields of papers citing papers by Christopher Godfrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Godfrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Godfrey. The network helps show where Christopher Godfrey may publish in the future.

Co-authorship network of co-authors of Christopher Godfrey

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Godfrey. A scholar is included among the top collaborators of Christopher Godfrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Godfrey. Christopher Godfrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Meyer, Thomas D., Christopher Godfrey, & Consuelo Walss‐Bass. (2022). The UT health Psychological Autopsy Interview Schedule (UTH- PAIS) – Description and reliability of diagnoses and transdiagnostic personality measures. Journal of Psychiatric Research. 156. 221–227. 4 indexed citations
2.
Godfrey, Christopher, et al.. (2022). Streptococcus agalactiae Infects Glial Cells and Invades the Central Nervous System via the Olfactory and Trigeminal Nerves. Frontiers in Cellular and Infection Microbiology. 12. 793416–793416. 7 indexed citations
3.
Godfrey, Christopher, et al.. (2022). Trauma and Emotion Regulation: Associations with Depressive Symptoms and Cocaine Use among Treatment-seeking Adults. International Journal of Mental Health and Addiction. 21(4). 2160–2174. 1 indexed citations
4.
Turner, Erlanger A., et al.. (2020). Therapy Fears and Help-Seeking Behaviors among Mothers: Examining Racial Differences in Mental Health Services. Community Mental Health Journal. 57(5). 808–813. 2 indexed citations
5.
Duque, Jaime S. Rosa, Daniel KL Cheuk, Patrick Ip, et al.. (2019). Risk factors for drug allergies in Chinese children. Asian Pacific Journal of Allergy and Immunology. 38(4). 271–278. 1 indexed citations
6.
Troy, Steven, Margaret Wasilewski, Jack M. H. Beusmans, & Christopher Godfrey. (2019). Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK‐611) in Children With Metachromatic Leukodystrophy. Clinical Pharmacology & Therapeutics. 107(6). 1394–1404. 8 indexed citations
7.
Godfrey, Christopher, Christopher H. Cabell, Barbara Balser, et al.. (2011). Exposure-QTc Response Analysis of Class 1 Selective Histone Deacetylase Inhibitor Romidepsin. Blood. 118(21). 2680–2680. 7 indexed citations
8.
Cabell, Christopher H., Susan E. Bates, Richard Piekarz, et al.. (2009). Systematic assessment of potential cardiac effects of the novel histone deacetylase (HDAC) inhibitor romidepsin. Journal of Clinical Oncology. 27(15_suppl). e19533–e19533. 9 indexed citations
9.
Cabell, Christopher H., Susan E. Bates, Richard Piekarz, et al.. (2009). Systematic Assessment of Potential Cardiac Effects of the Novel Histone Deacetylase (HDAC) Inhibitor Romidepsin.. Blood. 114(22). 3709–3709. 15 indexed citations
10.
Ette, Ene, Hui‐May Chu, & Christopher Godfrey. (2005). Data Supplementation: A Pharmacokinetic/Pharmacodynamic Knowledge Creation Approach for Characterizing an Unexplored Region of the Response Surface. Pharmaceutical Research. 22(4). 523–531. 2 indexed citations
11.
Godfrey, Christopher. (2004). The pharmacokinetics (PK) and pharmacodynamics (PD) of VX-702, a novel, oral P38MAP kinase inhibitor, in healthy volunteers. Clinical Pharmacology & Therapeutics. 75(2). P52–P52. 3 indexed citations
12.
Godfrey, Christopher, et al.. (2002). Bioavailability of Budesonide Delivered by the Clickhaler?? and Turbuhaler?? * Dry Powder Inhalers in Healthy Volunteers. Clinical Drug Investigation. 22(2). 119–124. 1 indexed citations
13.
Morton, David B., Anthony C Buckwell, Roger Ewbank, et al.. (2001). Refining procedures for the administration of substances. Laboratory Animals. 35(1). 1–41. 148 indexed citations
14.
Krauss, Herbert H., Christopher Godfrey, J M Kirk, & David M. Eisenberg. (1998). Alternative health care: Its use by individuals with physical disabilities. Archives of Physical Medicine and Rehabilitation. 79(11). 1440–1447. 53 indexed citations
15.
Godfrey, Christopher, et al.. (1998). The population pharmacokinetics of long‐term methotrexate in rheumatoid arthritis. British Journal of Clinical Pharmacology. 46(4). 369–376. 68 indexed citations
16.
Godfrey, Christopher. (1991). The Need for Change in Pharmaceutical Education: A Students Perspective. American Journal of Pharmaceutical Education. 55(4). 375–377. 2 indexed citations
17.
Godfrey, Christopher & James Epstein. (1977). Notes on Sources. Labour History Review. 34. 27–34.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marvin J. Rapaport Breakdown of academic impact, for papers by Gabriel P McKeon Breakdown of academic impact, for papers by Anthony M. Downs Breakdown of academic impact, for papers by Helen V. Ratajczak Breakdown of academic impact, for papers by Mohd Asnizam Asari Breakdown of academic impact, for papers by Qiaoling Li Breakdown of academic impact, for papers by J. A. Barnes Breakdown of academic impact, for papers by Xiaoyu Niu Breakdown of academic impact, for papers by Rashmi Srivastava Breakdown of academic impact, for papers by Sunil K Joshi
Rankless by CCL
2026